Boston Scientific Corporation (ETR:BSX)
Germany · Delayed Price · Currency is EUR 88.00
-1.60 (-1.79%)
At close: Aug 7, 2025, 5:30 PM CET
Longboard Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 2,506 | 1,854 | 1,593 | 698 | 1,041 | -82 | Upgrade |
Depreciation & Amortization | 1,315 | 1,269 | 1,196 | 1,136 | 1,093 | 1,123 | Upgrade |
Loss (Gain) From Sale of Assets | - | - | - | 22 | -78 | - | Upgrade |
Asset Writedown & Restructuring Costs | 156 | 386 | 58 | 132 | 370 | 533 | Upgrade |
Loss (Gain) From Sale of Investments | -158 | 79 | 59 | 1 | -250 | -333 | Upgrade |
Stock-Based Compensation | 286 | 266 | 233 | 220 | 194 | 170 | Upgrade |
Other Operating Activities | 135 | 43 | 134 | 322 | -149 | 120 | Upgrade |
Change in Accounts Receivable | -262 | -351 | -238 | -220 | -279 | 335 | Upgrade |
Change in Inventory | -53 | -228 | -660 | -321 | -346 | -65 | Upgrade |
Change in Accounts Payable | 468 | 243 | 118 | -255 | 408 | -28 | Upgrade |
Change in Other Net Operating Assets | -108 | -126 | 10 | -209 | -134 | -265 | Upgrade |
Operating Cash Flow | 4,285 | 3,435 | 2,503 | 1,526 | 1,870 | 1,508 | Upgrade |
Operating Cash Flow Growth | 62.80% | 37.23% | 64.02% | -18.40% | 24.01% | -17.87% | Upgrade |
Capital Expenditures | -800 | -790 | -711 | -588 | -554 | -376 | Upgrade |
Sale of Property, Plant & Equipment | 3 | 3 | 4 | 12 | 14 | 12 | Upgrade |
Cash Acquisitions | -5,793 | -4,640 | -1,811 | -1,542 | -2,258 | -3 | Upgrade |
Divestitures | - | - | - | 5 | 826 | 15 | Upgrade |
Sale (Purchase) of Intangibles | 20 | 20 | 30 | 70 | 82 | 87 | Upgrade |
Investment in Securities | -251 | -280 | -89 | -24 | 279 | -146 | Upgrade |
Other Investing Activities | 64 | - | 3 | 56 | 14 | - | Upgrade |
Investing Cash Flow | -6,757 | -5,687 | -2,574 | -2,011 | -1,597 | -411 | Upgrade |
Short-Term Debt Issued | - | 211 | - | - | - | 4,161 | Upgrade |
Long-Term Debt Issued | - | 2,145 | - | 3,270 | - | 1,683 | Upgrade |
Total Debt Issued | 1,769 | 2,356 | - | 3,270 | - | 5,844 | Upgrade |
Short-Term Debt Repaid | - | -504 | -4 | -251 | - | -5,583 | Upgrade |
Long-Term Debt Repaid | - | -25 | - | -3,184 | - | -1,260 | Upgrade |
Total Debt Repaid | -1,625 | -529 | -4 | -3,435 | - | -6,843 | Upgrade |
Net Debt Issued (Repaid) | 144 | 1,827 | -4 | -165 | - | -999 | Upgrade |
Issuance of Common Stock | 271 | 230 | 182 | 136 | 110 | 1,086 | Upgrade |
Repurchase of Common Stock | -87 | -87 | -56 | -53 | - | -535 | Upgrade |
Preferred Dividends Paid | - | - | -28 | -55 | -55 | -28 | Upgrade |
Dividends Paid | - | - | -28 | -55 | -55 | -28 | Upgrade |
Other Financing Activities | -214 | -156 | -89 | -411 | -150 | -206 | Upgrade |
Financing Cash Flow | 114 | 1,814 | 5 | -548 | -95 | 293 | Upgrade |
Foreign Exchange Rate Adjustments | 38 | -11 | -4 | -9 | -6 | -2 | Upgrade |
Miscellaneous Cash Flow Adjustments | -2 | -1 | - | - | 1 | - | Upgrade |
Net Cash Flow | -2,322 | -450 | -70 | -1,042 | 173 | 1,388 | Upgrade |
Free Cash Flow | 3,485 | 2,645 | 1,792 | 938 | 1,316 | 1,132 | Upgrade |
Free Cash Flow Growth | 89.30% | 47.60% | 91.05% | -28.72% | 16.25% | -17.67% | Upgrade |
Free Cash Flow Margin | 18.84% | 15.79% | 12.58% | 7.40% | 11.07% | 11.42% | Upgrade |
Free Cash Flow Per Share | 2.34 | 1.78 | 1.22 | 0.65 | 0.92 | 0.80 | Upgrade |
Cash Interest Paid | 250 | 250 | 259 | 450 | 338 | 359 | Upgrade |
Cash Income Tax Paid | 656 | 656 | 512 | 662 | 302 | 207 | Upgrade |
Levered Free Cash Flow | 2,938 | 1,808 | 1,880 | 1,155 | 2,654 | 1,110 | Upgrade |
Unlevered Free Cash Flow | 3,145 | 1,998 | 2,046 | 1,449 | 2,867 | 1,336 | Upgrade |
Change in Net Working Capital | -205 | 643 | 213 | 660 | -912 | 263 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.